NCT06550609View on ClinicalTrials.gov

Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis with Inhaled Pentamidine Plus Oral Miltefosine

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 4, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

February 29, 2028

Conditions
Mucosal Leishmaniasis
Interventions
DRUG

Miltefosine Oral Capsule

Miltefosine 3 pill per day during 28 days AND pentamidine inhaled 300 mg / d during 10 dosis

Trial Locations (1)

00000

RECRUITING

Hospital de Clinicas, La Paz

All Listed Sponsors
lead

Fundacion Nacional de Dermatologia

OTHER